JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow CME Activity
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chung, J.-K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chung, J.-K.

Sodium Iodide Symporter: Its Role in Nuclear Medicine*

June-Key Chung, MD, PhD1

1 Department of Nuclear Medicine, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea



View larger version (44K):

[in a new window]
 
FIGURE 1. Schematic illustration of NIS. NIS cotransports 2 sodium ions and 1 iodide ion. Sodium gradient provides energy for this transfer, as generated by Na+/K--adenosine triphosphatase.

 


View larger version (111K):

[in a new window]
 
FIGURE 2. Immunohistochemical staining and 131I whole-body scan findings of patient with papillary carcinoma. (A and B) In immunohistochemical staining (x200), cancer cells are immunostained for NIS (arrows). (C) Whole-body scan obtained 5 d after ingestion of 1.11 GBq 131I shows functional metastatic lesions (arrowhead) in right cervical lymph nodes. (D) Six months after second radioiodine therapy (total administered dose, 11.1 GBq), radioactivity in right neck had completely disappeared. (Reprinted with permission of (37).)

 


View larger version (100K):

[in a new window]
 
FIGURE 3. Immunohistochemical staining and 131I whole-body scan findings of patient with papillary carcinoma. (A and B) In immunohistochemical staining for NIS (x200), NIS protein was not detected in paraffin block sections of either primary tumor (A) or lymph node (B). (C) Whole-body scan obtained 5 d after ingestion of 1.11 GBq 131I shows no metastatic site; remnant thyroid activity is also shown (arrow). (D) 18F-FDG PET scan obtained 3 wk later shows abnormally increased 18F-FDG uptake on right side of neck and in mediastinum (arrowheads). (Reprinted with permission of (37).)

 


View larger version (69K):

[in a new window]
 
FIGURE 4. Whole-body photographic image (A) and scintigraphic image (B) of tumor-bearing nude mouse with subcutaneously transplanted wild-type human anaplastic thyroid cancer cells (ARO) (solid arrow) and rNIS-expressing cells (ARO-N) (open arrow) 30 min after injection of 131I.

 





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 2002 by the Society of Nuclear Medicine.